Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Titel:
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Auteur:
Garassino, Marina Chiara Martelli, Olga Broggini, Massimo Farina, Gabriella Veronese, Silvio Rulli, Eliana Bianchi, Filippo Bettini, Anna Longo, Flavia Moscetti, Luca Tomirotti, Maurizio Marabese, Mirko Ganzinelli, Monica Lauricella, Calogero Labianca, Roberto Floriani, Irene Giaccone, Giuseppe Torri, Valter Scanni, Alberto Marsoni, Silvia